In summary, the present study reports a novel model in which MUC1/ATAD3A/Pink1 axis-mediated mitophagy plays a crucial role in maintaining the malignant properties of cancer cells, providing a novel therapeutic target for the management of MUC1-positive breast cancers. This evidence concerns the gene PINK1 and breast carcinoma.